Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial-Reference-Cited by-同舟云学术

Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial

Published:2024-08 Issue:8 Volume:5 Page:e563-e573
ISSN:2666-7568
Container-title:The Lancet Healthy Longevity
language:en
Short-container-title:The Lancet Healthy Longevity

Author:

Sheppard James P^ORCID,Temple Eleanor,Wang Ariel^ORCID,Smith Anne,Pollock Stephanie,Ford Gary A,Hobbs F D Richard,Kenealy Nicola,Little Paul,Lown Mark,de Lusignan Simon,Mant Jonathan,McCartney David,Payne Rupert A,Williams Marney,Yu Ly-Mee,McManus Richard J

Publisher

Elsevier BV

Reference35 articles.

1. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis;Rahimi;Lancet,2021

2. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial;Williamson;JAMA,2016

3. Treatment of hypertension in patients 80 years of age or older;Beckett;N Engl J Med,2008

4. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis;Albasri;BMJ,2021

5. The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study;Sheppard;PLoS Med,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deprescribing for older adults with hypertension at high risk for adverse events: not so fast;The Lancet Healthy Longevity;2024-08